Stalevo in Early Wearing-Off Patients

NCT00125567 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Parkinson's Disease

Interventions

DRUG: Stalevo (levodopa/carbidopa/entacapone)
DRUG: Levodopa/carbidopa

Sponsor

Orion Corporation, Orion Pharma